Released : Thursday, November 20, 2008 8:01 PM
2008 NOV 27 - (NewsRx.com)
-- According to recent research published in the Journal of
Biomedical Materials Research Part B - Applied Biomaterials,
"Two different approaches were used to fabricate porous scaffolds,
and their in vitro drug releasing characteristics were examined (see
also Tissue
Engineering). In the first method, a poly(I-lactic acid) (PLLA)
solution and poly(vinyl alcohol) (PVA) + acetaminophen solution was
homogenized."
"The emulsion was then blended with a PLLA solution in
chloroform. The resultant emulsion was freeze-dried to form porous
scaffolds. Various combinations were obtained by varying homogenizer
speed and blender speed, and by varying the concentration of PVA and
acetaminophen solutions. The in vitro drug-release study was
performed for 6 days in a phosphate buffer. The influence of
structure, porosity, and drug concentration of the scaffolds on
drug-release rate was examined using design of experiments. In the
second approach, scaffolds were prepared in layered constructs, with
either a three-layered or five-layered structure. The PVA +
acetaminophen solution was blended with PLLA solution using a
blender. The drug-release study was performed for 19 days," wrote M.
Uttarwar and colleagues, University of Texas.
The researchers concluded: "The effect of drug concentration,
blender speed, and the thickness of the layers on drug-release rate
was examined."
Uttarwar and colleagues published their study in the Journal
of Biomedical Materials Research Part B - Applied Biomaterials
(Fabrication of porous, drug-releasing, biodegradable, polymer
scaffolds for sustained drug release. Journal of Biomedical
Materials Research Part B - Applied Biomaterials,
2008;87B(1):121-131).
For additional information, contact P. Aswath, University of
Texas Arlington, Dept. of Materials Science & Engineering,
Arlington, TX 76019, USA.
The publisher's contact information for the Journal of
Biomedical Materials Research Part B - Applied Biomaterials is:
Wiley-Liss, Division John Wiley & Sons Inc., 111 River St.,
Hoboken, NJ 07030, USA.
Copyright 2008 Blood Weekly via NewsRx.com
Provider:
NewsRx.com / Blood Weekly
Keywords:
Alternative
Technologies, Molecular
& Cellular Biology, Biotechnology
Industry Trends & Policy, Biomaterials,
North
American Biotechnology, Biopharmaceuticals,
Biotechnology,
U.S.
Business News, Business
News, Chemicals,
General
Clinical Healthcare